Skip to content

North Carolina · Nonprofit

ASHEVILLE MEDICAL RESEARCH CORPORATION

ASHEVILLE MEDICAL RESEARCH CORPORATION (North Carolina) receives grants from 1 organization whose IRS filings report $20,000 to it, the largest being DOGWOOD HEALTH TRUST ($20,000). 0 of them have funded it in more than one year.

Revenue FY2025
$384k
Funders on record
1
Grants received
$20k
Net assets
$375k
0/1 repeat funders
01What it does

What Asheville Medical Research Corporation does

Mission

Medical Research and Education

As stated on its FY2025 Form 990.

Programs

  1. Significant expansion of a medical research study funded by the Duke Foundation for the benefit of regional military veterans.

    $14,430 spent$14,430 earned by the program
    6% of program spending
  2. Medical Research study funded by Novartis pharmaceutical for the benefit of regional service veterans.

    $93,343 spent$93,343 earned by the program
    40% of program spending
  3. Overlapping education related studies funded by the North Carolina Office of Digital Technology for the benefit of providing technical resources and knowledge to in need qualifying regional veterans.

    $123,790 spent$123,790 earned by the program
    53% of program spending
  4. Other program services, not described on the e-filed return.

    $0 spent
    0% of program spending

The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $231,563.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($25k) Expenses 100 ($93k) Net assets 100 ($259k)2018 Revenue 479 ($118k) Expenses 184 ($171k) Net assets 80 ($206k)2019 Revenue 501 ($124k) Expenses 202 ($187k) Net assets 56 ($144k)2020 Revenue 627 ($155k) Expenses 140 ($130k) Net assets 65 ($169k)2021 Revenue 458 ($113k) Expenses 108 ($100k) Net assets 70 ($180k)2022 Revenue 341 ($84k) Expenses 133 ($123k) Net assets 54 ($141k)2023 Revenue 401 ($99k) Expenses 92 ($86k) Net assets 59 ($154k)2024 Revenue 917 ($226k) Expenses 96 ($89k) Net assets 112 ($291k)2025 Revenue 1558 ($384k) Expenses 323 ($300k) Net assets 145 ($375k)
'17'18'19'20'21'22'23'24'25
Revenue (1558)Expenses (323)Net assets (145)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $156k to $327k (+110%).

$265k
$217k
$152k
$180k
$183k
$145k
$156k
$327k
$382k
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

4% of ASHEVILLE MEDICAL RESEARCH CORPORATION’s revenue is contributions — more earned-revenue than three-quarters of its peers (82% for the typical peer).

This organization
Typical peer · 14,893 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 9 reported years ran a deficit.

−$68k
’17
−$53k
’18
−$64k
’19
$25k
’20
$13k
’21
−$39k
’22
$13k
’23
$137k
’24
$84k
’25
13
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Kristi Knight

Interim Executive Director

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed675555655
Joined·+2+1+0+2+0+1+1+1
No longer listed·13020021
03Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

Funder
'24*
total
funders
1

From the IRS filings of ASHEVILLE MEDICAL RESEARCH CORPORATION’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

100% of ASHEVILLE MEDICAL RESEARCH CORPORATION's grant income comes from North Carolina funders.

NC

Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

ASHEVILLE MEDICAL RESEARCH CORPORATION has grown faster than three-quarters of the 7,883 health nonprofits its size.

Operating margin22% · above the median
Months of reserve13.4mo · above the median
Revenue growth (annualized)41% · top quartile

this organization peer median middle 50% of peers· 7,883 health nonprofits $100k–$1M, FY2025

Organizations like ASHEVILLE MEDICAL RESEARCH CORPORATION

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In North Carolina

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

77% of spending goes to programs.

Program 77%Management 23%Fundraising 0%

Governance

7
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Footprint & structure

Files a return copy in 1 state

NC

Screen this organization

A dated, signed PDF of the compliance screen for ASHEVILLE MEDICAL RESEARCH CORPORATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds ASHEVILLE MEDICAL RESEARCH CORPORATION?
ASHEVILLE MEDICAL RESEARCH CORPORATION (North Carolina) receives grants from 1 organization whose IRS filings report $20,000 to it, the largest being DOGWOOD HEALTH TRUST ($20,000). 0 of them have funded it in more than one year.
How many funders does ASHEVILLE MEDICAL RESEARCH CORPORATION have?
IRS filings report 1 organization giving $20,000 in grants to ASHEVILLE MEDICAL RESEARCH CORPORATION.
Who is the largest funder of ASHEVILLE MEDICAL RESEARCH CORPORATION?
DOGWOOD HEALTH TRUST is the largest funder on record, with $20,000 in grants. The full list of funders is on this page.
How can an organization like ASHEVILLE MEDICAL RESEARCH CORPORATION find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in North Carolina. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing